These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 9105096)
1. Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. Parsons PE; Moss M; Vannice JL; Moore EE; Moore FA; Repine JE Am J Respir Crit Care Med; 1997 Apr; 155(4):1469-73. PubMed ID: 9105096 [TBL] [Abstract][Full Text] [Related]
2. [Changes of plasma interleukin-4, interleukin-10 and interleukin-13 in patients with acute respiratory distress syndrome]. Li Q; Qian G; Zhang Q; Gong J; Tang Z; Gao Z Zhonghua Jie He He Hu Xi Za Zhi; 2002 Nov; 25(11):661-4. PubMed ID: 12490119 [TBL] [Abstract][Full Text] [Related]
3. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Park WY; Goodman RB; Steinberg KP; Ruzinski JT; Radella F; Park DR; Pugin J; Skerrett SJ; Hudson LD; Martin TR Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1896-903. PubMed ID: 11734443 [TBL] [Abstract][Full Text] [Related]
4. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns. Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178 [TBL] [Abstract][Full Text] [Related]
6. Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury. Mandrup-Poulsen T; Wogensen LD; Jensen M; Svensson P; Nilsson P; Emdal T; Mølvig J; Dinarello CA; Nerup J Crit Care Med; 1995 Jan; 23(1):26-33. PubMed ID: 8001382 [TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory cytokine levels in patients with septic shock. Kasai T; Inada K; Takakuwa T; Yamada Y; Inoue Y; Shimamura T; Taniguchi S; Sato S; Wakabayashi G; Endo S Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):34-42. PubMed ID: 9434313 [TBL] [Abstract][Full Text] [Related]
9. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma. O'Nualláin EM; Puri P; Mealy K; Reen DJ Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873 [TBL] [Abstract][Full Text] [Related]
10. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325 [TBL] [Abstract][Full Text] [Related]
11. Early alveolar and systemic mediator release in patients at different risks for ARDS after multiple trauma. Raymondos K; Martin MU; Schmudlach T; Baus S; Weilbach C; Welte T; Krettek C; Frink M; Hildebrand F Injury; 2012 Feb; 43(2):189-95. PubMed ID: 21703617 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients. Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878 [TBL] [Abstract][Full Text] [Related]
13. Protective effect of interleukin-1 receptor antagonist on oleic acid-induced lung injury. Sun D; Zhao M; Ma D; Liao S; Di C Chin Med J (Engl); 1996 Jul; 109(7):522-6. PubMed ID: 9206098 [TBL] [Abstract][Full Text] [Related]
14. Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology? Capper ER; Maskill JK; Gordon C; Blakemore AI Clin Exp Immunol; 2004 Nov; 138(2):348-56. PubMed ID: 15498048 [TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis. Fisher CJ; Opal SM; Lowry SF; Sadoff JC; LaBrecque JF; Donovan HC; Lookabaugh JL; Lemke J; Pribble JP; Stromatt SC Circ Shock; 1994 Sep; 44(1):1-8. PubMed ID: 7704933 [TBL] [Abstract][Full Text] [Related]
16. Serum ferritin as a predictor of the acute respiratory distress syndrome. Connelly KG; Moss M; Parsons PE; Moore EE; Moore FA; Giclas PC; Seligman PA; Repine JE Am J Respir Crit Care Med; 1997 Jan; 155(1):21-5. PubMed ID: 9001283 [TBL] [Abstract][Full Text] [Related]
17. Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity. Kurdowska A; Noble JM; Steinberg KP; Ruzinski JT; Hudson LD; Martin TR Am J Respir Crit Care Med; 2001 Feb; 163(2):463-8. PubMed ID: 11179123 [TBL] [Abstract][Full Text] [Related]
18. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass. Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172 [TBL] [Abstract][Full Text] [Related]
19. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals. Netea MG; Hancu N; Blok WL; Grigorescu-Sido P; Popa L; Popa V; van der Meer JW Cytokine; 1997 Apr; 9(4):284-7. PubMed ID: 9112337 [TBL] [Abstract][Full Text] [Related]
20. Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome. Sharkey RA; Donnelly SC; Connelly KG; Robertson CE; Haslett C; Repine JE Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1506-9. PubMed ID: 10228118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]